» Articles » PMID: 23792273

Sequestosome1/p62: a Regulator of Redox-sensitive Voltage-activated Potassium Channels, Arterial Remodeling, Inflammation, and Neurite Outgrowth

Overview
Date 2013 Jun 25
PMID 23792273
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Sequestosome1/p62 (SQSTM1) is an oxidative stress-inducible protein regulated by the redox-sensitive transcription factor Nrf2. It is not an antioxidant but known as a multifunctional regulator of cell signaling with an ability to modulate targeted or selective degradation of proteins through autophagy. SQSTM1 implements these functions through physical interactions with different types of proteins including atypical PKCs, nonreceptor-type tyrosine kinase p56(Lck) (Lck), polyubiquitin, and autophagosomal factor LC3. One of the notable physiological functions of SQSTM1 is the regulation of redox-sensitive voltage-gated potassium (Kv) channels which are composed of α and β subunits: (Kvα)4 (Kvβ)4. Previous studies have established that SQSTM1 scaffolds PKCζ, enhancing phosphorylation of Kvβ which induces inhibition of pulmonary arterial Kv1.5 channels under acute hypoxia. Recent studies reveal that Lck indirectly interacts with Kv1.3 α subunits and plays a key role in acute hypoxia-induced Kv1.3 channel inhibition in T lymphocytes. Kv1.3 channels provide a signaling platform to modulate the migration and proliferation of arterial smooth muscle cells and activation of T lymphocytes, and hence have been recognized as a therapeutic target for treatment of restenosis and autoimmune diseases. In this review, we focus on the functional interactions of SQSTM1 with Kv channels through two key partners aPKCs and Lck. Furthermore, we provide molecular insights into the functions of SQSTM1 in suppression of proliferation of arterial smooth muscle cells and neointimal hyperplasia following carotid artery ligation, in T lymphocyte differentiation and activation, and in NGF-induced neurite outgrowth in PC12 cells.

Citing Articles

p62/SQSTM1 in cancer: phenomena, mechanisms, and regulation in DNA damage repair.

Yang X, Cao X, Zhu Q Cancer Metastasis Rev. 2025; 44(1):33.

PMID: 39954143 PMC: 11829845. DOI: 10.1007/s10555-025-10250-w.


Interplay among Oxidative Stress, Autophagy, and the Endocannabinoid System in Neurodegenerative Diseases: Role of the Nrf2- p62/SQSTM1 Pathway and Nutraceutical Activation.

Armeli F, Mengoni B, Laskin D, Businaro R Curr Issues Mol Biol. 2024; 46(7):6868-6884.

PMID: 39057052 PMC: 11276139. DOI: 10.3390/cimb46070410.


Skin barrier-inflammatory pathway is a driver of the psoriasis-atopic dermatitis transition.

Dong S, Li D, Shi D Front Med (Lausanne). 2024; 11:1335551.

PMID: 38606161 PMC: 11007107. DOI: 10.3389/fmed.2024.1335551.


Unleashing the Potential of Nrf2: A Novel Therapeutic Target for Pulmonary Vascular Remodeling.

Fang Q, Bai Y, Hu S, Ding J, Liu L, Dai M Antioxidants (Basel). 2023; 12(11).

PMID: 38001831 PMC: 10669195. DOI: 10.3390/antiox12111978.


PPARG agonist pioglitazone influences diurnal kidney medulla mRNA expression of core clock, inflammation-, and metabolism-related genes disrupted by reverse feeding in mice.

Izmailova O, Kabaliei A, Shynkevych V, Shlykova O, Kaidashev I Physiol Rep. 2022; 10(23):e15535.

PMID: 36511486 PMC: 9746034. DOI: 10.14814/phy2.15535.